Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:

• Comparisons of available CMV antiviral therapies:
  • Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavir
• Considerations for renal function monitoring with ganciclovir and valganciclovir
• A treatment algorithm for relapsed/refractory CMV
• The latest clinical trial data and guideline recommendations

Presenter:
Atul Humar, MD, FRCP (C) 
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada

Link to full program:
https://bit.ly/4lOa2kA

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.